Tumors of ampulla of Vater: A case series and review of chemotherapy options
Carcinomas of the Ampulla of Vater are rare tumors, accounting for 0.2% of gastrointestinal cancers. Compared with other biliary tract neoplasms, these tumors have a relatively favorable prognosis after surgical resection. Based on their epithelium of origin, two subtypes of ampullary carcinoma have...
Saved in:
Published in | World journal of gastrointestinal oncology Vol. 4; no. 3; pp. 60 - 67 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
China
Baishideng Publishing Group Co., Limited
15.03.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Carcinomas of the Ampulla of Vater are rare tumors, accounting for 0.2% of gastrointestinal cancers. Compared with other biliary tract neoplasms, these tumors have a relatively favorable prognosis after surgical resection. Based on their epithelium of origin, two subtypes of ampullary carcinoma have been recently distinguished: intestinal and pancreatobiliary. This study evaluates histopathological features and outcomes of ampullary carcinoma and to compares the survival of these tumors to that of other biliary tract tumors. The chemotherapic options available for ampullary cancer are also reviewed. We analyzed data from 20 consecutive patients with ampullary carcinomas and 26 patients with other biliary tract carcinomas, observed in our Institution. Statistical analysis was performed by using either Fisher’s exact test or χ2 test for categorical variables. Median time of survival was calculated and compared using the Log-Rank test. Similar distribution of demographic characteristics and stage between ampullary and other biliary tract cancers was observed. Patients with ampullary cancer underwent surgery more frequently than other biliary cancers while chemotherapy and radiotherapy were used equally. In accordance with the literature, a longer median survival was observed in the group of ampullary carcinomas. |
---|---|
Bibliography: | Adriana Romiti, Viola Barucca, Angelo Zullo, Ida Sarcina, Roberta Di Rocco, Chiara D’Antonio, Marco Latorre, Paolo Marchetti , Oncology Unit, University "La Sapienza", Sant’Andrea Hospital, via di Grottarossa 1035, 00189 Rome, Italy , Gastroenterology and Digestive Endoscopy, "Nuovo Regina Margherita" Hospital, via Morosini 30, 00185 Rome, Italy , Department of General Surgery, University "La Sapienza", Sant’Andrea Hospital, via di Grottarossa 1035, 00189 Rome, Italy ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Telephone: +39-6-33775656 Fax: +39-6-33776629 Correspondence to: Dr. Adriana Romiti, Professor, Oncology Unit, University “La Sapienza”, Sant’Andrea Hospital, via Grottarossa 1035, 00189 Rome, Italy. adriana.romiti@tin.it Author contributions: All authors contributed to this paper. |
ISSN: | 1948-5204 1948-5204 |
DOI: | 10.4251/wjgo.v4.i3.60 |